Pearl develops AI-driven dental software that reads and instantly identifies disease in dental X-rays and introduced the first-ever FDA-cleared AI for this purpose. The company was founded in 2019 by a team with decades of enterprise computer vision experience and is led by founder and CEO Ophir Tanz. Pearl's platform has regulatory clearance in 120 countries and is used to assist dentists in making clinical decisions and communicating with patients. The company emphasizes tools that add a cognitive layer to digital dentistry workflows while keeping clinicians in control of decision-making. Pearl positions itself as dentistry's global AI leader and is committed to ongoing innovation and making robust, accessible AI tools that improve patient health outcomes. The ADA's recent strategic investment underscores support from major dental organizations and signals institutional interest in integrating AI into dental practice. Pearl develops AI-powered computer-vision software that assists dentists by identifying dental disease on X-rays and providing a “second opinion.” The company holds one of only three FDA clearances for AI-assisted dental diagnosis and emphasizes that its tool highlights areas of interest while leaving final clinical judgment to dentists. Pearl says dentists using its software see on average a 30% boost in patients agreeing to recommended treatments. The startup was incubated inside GumGum by founder and CEO Ophir Tanz and spun out in 2019. Pearl’s revenue grew 458% in 2023, and the company expects rapid continued adoption, with the CEO forecasting global standard-of-care uptake within about three years. Pearl competes with other FDA-cleared startups including Video Health and Overjet. Pearl builds artificial intelligence solutions for dentistry, offering a less invasive approach to dental diagnostics. Its FDA-cleared AI software helps dentists improve the efficiency, consistency, and accuracy of x-ray evaluations. The platform also streamlines practice operations by providing actionable clinical performance and patient health insights. Led by CEO Ophir Tanz, the company plans to use new funding to expand operations and accelerate development efforts. Management has stated an intention to further expand Pearl's reach to dental practices globally. The article does not disclose revenue, users, or other financial metrics. Pearl is a healthcare spinout from GumGum focused on applying machine learning to the dental industry. Led by GumGum cofounder Ophir Tanz, the company develops AI-driven tools that analyze dental x-rays, provide diagnostics, and deliver practice analytics. It is coming to market with three products: Second Opinion (x-ray pathology and anatomy detection), Practice Intelligence (advanced analytics for practices and groups), and Smart Margin (feedback on intraoral scans for restorations and manufacturers). Pearl raised $11 million in financing from Craft Ventures and undisclosed strategic investors to build out its toolkit for teeth. The technology aims to reduce insurer fraud, validate network dentist performance, and automate workflows inside dental offices. The company plans to focus on dentistry initially and eventually expand into other healthcare verticals while improving standard of care and streamlining repetitive tasks.

Total raised

$69M

Funding rounds

4

Latest round

Series B

Latest activity

Jul 2024